Qure.ai, a global leader in artificial intelligence
(AI) for healthcare, today announced the launch of India’s first AI-led
Incidental Pulmonary Nodule (IPN) Detection Clinic at Thangam Cancer Centre in
Namakkal, Tamil Nadu.
This
initiative is part of Project BreatheEZ, a broader strategic collaboration
between Qure.ai and Johnson & Johnson MedTech, India, designed to establish
AI-powered IPN Clinics across leading hospitals in India. These clinics will
act as integrated screening hubs, optimizing early detection, triaging, and
follow-up care for lung cancer patients.
The Thangam Cancer Centre IPN Clinic is India’s
first dedicated Incidental Pulmonary Nodule (IPN) clinic designed to systematically
detect and track lung nodules using Qure.ai’s FDA-cleared qXR solution as part
of an integrated screening and care pathway. This structured, AI-powered
incidental screening program, established within a hospital setting will enable
the detection of nodules as small as 6mm from routine chest X-rays. This
minimally invasive, cost-effective approach unlocks the possibility of
diagnosing lung cancer at an early stage, giving patients significantly better
chances of survival and improved outcomes.
Speaking about the launch, Dr. Saravana
Rajamanickam MS, MCh, Director, Surgical
Thoracic Oncology, Thangam Cancer Centre & Research Institute, said, "Our vision has always been
to bring the best of global healthcare technology to the people . With the launch
of this AI-powered clinic, we are not only enhancing our ability to detect lung
cancer early but also redefining cancer care for millions in India. Combining
the precision of AI with advanced surgical techniques like robotics gives us a
comprehensive pathway from early detection to advanced treatment, all under one
roof."
Qure.ai’s qXR technology works by automatically
flagging pulmonary nodules, often early indicators of lung cancer, on routine
chest X-rays. The AI system also assists radiologists by providing malignancy
risk scores, tracking nodule progression over time, and ensuring seamless care
coordination between radiology, pulmonology, and oncology teams.
Prashant Warier, CEO and Co-Founder, Qure.ai, said,
"At Qure.ai, we are committed to bridging
critical healthcare gaps with AI. The partnership with Thangam Cancer Centre to
turn routine chest X-rays into early warning tools is a powerful example of the
potential of our AI solutions. We look forward to scaling this model across
India’s healthcare ecosystem."
This hub-and-spoke model, piloted at Thangam Cancer
Centre, is expected to serve as a blueprint for similar AI-powered clinics
across India, supported by Johnson & Johnson MedTech, India.
Lung cancer remains one of world’s deadliest
cancers, largely due to late-stage diagnosis. India clocks ~112,000 new lung cancer
cases1, annually with only ~4% cases2 detected at an
early stage. Most patients are detected only when symptoms appear, by which
time treatment options are limited. This first-of-its-kind AI-powered clinic
brings hope for earlier detection, especially for non-smoking patients, who now
make up a growing proportion of lung cancer cases in India and the rest of the
world.
About Qure.ai
Qure.ai is a health tech company that uses deep
learning and Artificial Intelligence (AI) to make healthcare more accessible
and equitable for patients worldwide. Our solutions power the efficient
identification and management of Tuberculosis (TB), Lung Cancer and Stroke to
support clinicians and propel developments in the pharmaceutical and medical
device industries. We empower healthcare by helping to identify conditions
fast, prioritize treatment planning and ultimately improve quality of patient
life.
For media queries:
Qure.ai
Amrutha Joseph - Amrutha.joseph@qure.ai
Reference: